Imricor Announces Sales Collaboration with Optoacoustics
12 Agosto 2020 - 8:00AM
Business Wire
Imricor Medical Systems, Inc. (Company or
Imricor) (ASX:IMR), the global leader in MRI-guided
cardiac ablation products, is pleased to announce a sales
collaboration with Optoacoustics Ltd, the world leader in
innovative, high performance optical communication solutions for
magnetic resonance (MR) applications.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200812005231/en/
Imricor Announces Sales Collaboration
With Optoacoustics (Photo: Business Wire)
The collaboration establishes a formal relationship between
Imricor and Optoacoustics to facilitate the introduction of the
IMROC IRTM Wireless Multichannel Communication System to Imricor
customers. IMROC provides wireless noise cancelling MRI headsets
that can be used by up to 8 participants simultaneously, including
the patient. The system was developed specifically for use in iCMR
environments.
Given the noise and complexities of MRI, normal conversation can
be difficult during iCMR procedures. The IMROC IR System is the
first multichannel wireless audio system in the world to operate
without RF. The system uses light waves for transmission with no
impact on MRI imaging, enabling calm, clear dialog between doctors
and technicians.
“Optoacoustics is a well-known company in the communication
space. The technology is very innovative and supports our overall
strategy of bringing cardiac interventions into the iCMR,” said
Nick Twohy, Imricor’s Director of Marketing.
Imricor products are specifically designed to work under
real-time MRI guidance, with the intent of enabling higher success
rates along with a faster and safer treatment compared to
conventional procedures using x-ray guided catheters. Imricor is
the first and only company to offer cardiac ablation devices for
use in the MRI environment.
Dr. Yuvi Kahana, CEO and Co-Founder of Optoacoustics, stated,
“We're thrilled and excited - it's hard to imagine a better fit for
IMROC. Imricor's advances in cardiac catheter ablation highlight
the productive benefits of simple, comfortable communications among
iCMR staff, and IMROC provides the most effective and robust noise
cancelling solution available.”
About Imricor
Please visit http://imricor.com/investors/about-imricor/ for
more information about Imricor, Foreign Ownership Restrictions, and
Forward-Looking Statements.
About Optoacoustics
Optoacoustics Ltd is the world’s leading provider of noise
cancelling optical headphones and microphones for MRI. Please visit
http://www.optoacoustics.com/medical for more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200812005231/en/
Investors: Steve Wedan Executive Chair, President and CEO
Email: steve.wedan@imricor.com Investors & Australia
Media: Carrie Barrack Senior Advisor, Cato & Clive Email:
carrie@catoandclive.com Phone: +61 422 464 028 Rest of World
Media: Nick Twohy Director of Marketing, Imricor Email:
nick.twohy@imricor.com Phone: +1 952 818 8407
iMetal Resources (TSXV:IMR)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
iMetal Resources (TSXV:IMR)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025